Long-term conditions
Women can be protected from cervical cancer – so why aren’t we doing it?
Amid a global shortage of HPV vaccine, more must be done to steer supplies towards those most at risk: girls in poor countries This is keep reading
cancer prevention
Long-term conditions
Mass cervical cancer vaccine rollout may save 62 million lives in next 100 years
Studies estimate rapidly deploying HPV vaccine in 78 of the world’s poorest countries could help prevent over 74 million cases This is an edited version keep reading